Mentor is rolling out its new CPX4 tissue expander for use in breast reconstruction after mastectomy.cpx4

The new expander became available in the Europe, Middle East, and Africa (EMEA) markets on June 12, 2013. The company received FDA approval for the U.S. market in April.

This expander is intended for temporary subcutaneous or submuscular implantation and is not intended for use beyond 6 months.

The CPX4 expander joins the CPX Family of Tissue Expander Products, which include proprietary features such as the BufferZone® Self?Sealing Patch and SILTEX® Imprinted Texture.

The BufferZone® Patch surrounds the integral injection dome to protect at least 50% more of the expander surface area (than the injection dome alone) from accidental needle puncture to minimize and/or prevent device leakage and the need for additional surgery. The unique SILTEX® Imprinted Texture does not require the use of salt or sugar crystals.

According to Mentor, the injection dome magnet is 48% stronger than the CONTOUR PROFILE® Tissue Expanders, CPX™2 Tissue Expander, and CPX™3 Tissue Expander, which makes it easier to find the injection dome under the patient’s skin. The softer, more flexible BufferZone Self?Sealing Patch is designed to help ease surgical insertion and removal.